mice

Mutant cohesin in premature ovarian failure.

Caburet S, Arboleda VA, Llano E, Overbeek PA, Barbero JL, Oka K, et al. Mutant cohesin in premature ovarian failure. N Engl J Med. 2014;370(10):943-9. doi: 10.1056/NEJMoa1309635. PubMed PMID: 24597867.

Pancreatic safety of incretin-based drugs--FDA and EMA assessment.

Egan AG, Blind E, Dunder K, de Graeff PA, Hummer TB, Bourcier T, et al. Pancreatic safety of incretin-based drugs--FDA and EMA assessment. N Engl J Med. 2014;370(9):794-7. doi: 10.1056/NEJMp1314078. PubMed PMID: 24571751.

Hepatic UDP-glucuronosyltransferase is responsible for eslicarbazepine glucuronidation.

Loureiro AI, Fernandes-Lopes C, Bonifácio MJ, Wright LC, Soares-da-Silva P. Hepatic UDP-glucuronosyltransferase is responsible for eslicarbazepine glucuronidation. Drug Metab Dispos. 2011;39(9):1486-94. doi: 10.1124/dmd.111.038620. PubMed PMID: 21673130.

Mistargeting of peroxisomal EHHADH and inherited renal Fanconi's syndrome.

Klootwijk ED, Reichold M, Helip-Wooley A, Tolaymat A, Broeker C, Robinette SL, et al. Mistargeting of peroxisomal EHHADH and inherited renal Fanconi's syndrome. N Engl J Med. 2014;370(2):129-38. doi: 10.1056/NEJMoa1307581. PubMed PMID: 24401050.

Proteome-wide analysis and CXCL4 as a biomarker in systemic sclerosis.

van Bon L, Affandi AJ, Broen J, Christmann RB, Marijnissen RJ, Stawski L, et al. Proteome-wide analysis and CXCL4 as a biomarker in systemic sclerosis. N Engl J Med. 2014;370(5):433-43. doi: 10.1056/NEJMoa1114576. PubMed PMID: 24350901.

PET imaging shows loss of striatal PDE10A in patients with Huntington disease.

Ahmad R, Bourgeois S, Postnov A, Schmidt ME, Bormans G, Van Laere K, et al. PET imaging shows loss of striatal PDE10A in patients with Huntington disease. Neurology. 2014;82(3):279-81. doi: 10.1212/WNL.0000000000000037. PubMed PMID: 24353339.